DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...

器械之家医疗器械媒体报道先锋分享专业医疗器械知识关注 来源：器械之家，未经授权不得转载，且24小时后方可转载近日，全球领先的连续血糖监测仪（CGM）龙头Dexcom宣布，已向智能戒指制造商Ōura投资7500万美元（约折合5.4亿人民币），并达成战略 ...

The CGM market is practically a duopoly that DexCom shares with Abbott Laboratories. DexCom's success in this market explains ...

In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target of ...

DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), ...

Citi raised the firm’s price target on DexCom (DXCM) to $91 from $85 and keeps a Buy rating on the shares as part of a 2025 outlook for the ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...

DexCom, Inc. (DXCM), headquartered in California, is a leading player in the medical devices sector. Valued at a market cap ...

Dexcom Inc. (NASDAQ:DXCM) 近期报告了一项涉及其执行副总裁兼首席人力资源官Sadie Stern的股票交易。根据SEC Form 4文件显示，Stern于2024年11月20日以每股74.73美元的价格出售了4,259股普通股。此次出售的总价值为318,275美元。

Tandem Diabetes Care announced today that t:slim X2 insulin pump users in Canada can now access full compatibility with ...

In the assessment of 12-month price targets, analysts unveil insights for DexCom, presenting an average target of $98.44, a ...

Marisa Cardinal, an Alberta mother of six, was diagnosed with type 2 diabetes about 17 years ago after the birth of her ...